A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

被引：0
|
作者：
Ma, K. [1 ]
Xu, Y. [1 ]
Cai, Y. [1 ]
Wang, X. [1 ]
Sun, C. [1 ]
Guo, Y. [1 ]
Qiu, S. [1 ]
机构：
[1] First Hosp Jilin Univ, Changchun, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
small-cell lung cancer; Apatinib; Phase II;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP10.05
引用
收藏
页码：S216 / S217
页数：2
相关论文
共 50 条
  • [41] A multicenter, prospective study of apatinib plus chemotherapy as neoadjuvant treatment for locally advanced gastric cancer
    Tang, Y-H.
    Wang, F-H.
    Lin, G-J.
    Lin, J-X.
    Zheng, C-H.
    Li, P.
    Xie, J-W.
    Wang, J-B.
    Lu, J.
    Chen, Q-Y.
    Cao, L-L.
    Lin, M.
    Tu, R-H.
    Huang, Z-N.
    Lin, J-L.
    Zheng, H-L.
    Huang, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S1300 - S1300
  • [42] Phase II study of paclitaxel and irinotecan chemotherapy in patients with advanced nonsmall cell lung cancer
    Oshita, Fumihiro
    Saito, Haruhiro
    Yamada, Kouzo
    Noda, Kazumasa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (04): : 358 - 360
  • [43] Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer
    Stewart, DJ
    Tomiak, E
    Shamji, FM
    Maziak, DE
    MacLeod, P
    LUNG CANCER, 2004, 44 (02) : 241 - 249
  • [44] Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study
    Neumair, P.
    Joos, L.
    Warschkow, R.
    Ess, S.
    Hitz, F.
    Frueh, M.
    Brutsche, M. H.
    Baty, F.
    Krahenbuhl, S.
    Jorger, M.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S131 - S131
  • [45] A retrospective analysis of apatinib in advanced non-small cell lung cancer patients refractory to chemotherapy.
    Xu, Jianping
    Liu, Xiaoyan
    Yang, Sheng
    Zhang, Xiangru
    Shi, Yuankai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study
    Gridelli, C
    Rossi, A
    Scognamiglio, F
    Guida, C
    Fiore, F
    Gatani, T
    Scoppa, G
    Pergola, M
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4755 - 4758
  • [47] Phase II study of raltitrexed (Tomudex®) in chemotherapy-pretreated patients with advanced colorectal cancer
    Sato, A
    Kurihara, M
    Horikoshi, N
    Aiba, K
    Kikkawa, N
    Shirouzu, K
    Mitachi, Y
    Sakata, Y
    Wakui, A
    ANTI-CANCER DRUGS, 1999, 10 (08) : 741 - 748
  • [48] Efficacy, safety, and prognostic factors of apatinib plus platinum doublet chemotherapy in advanced non-small cell lung cancer
    Xu, Jianping
    Liu, Xiaoyan
    Yang, Sheng
    Shi, Yuankai
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (05) : 1425 - +
  • [49] A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer
    Kasahara, Kazuo
    Kimura, Hideharu
    Shibata, Kazuhiko
    Araya, Tomoyuki
    Sone, Takashi
    Oribe, Yoshitaka
    Furusho, Shiho
    Kita, Toshiyuki
    Shirasaki, Hiroki
    Oribe, Yoshitaka
    Yoshimi, Yuzo
    Ueda, Akihito
    Tachibana, Hideki
    Shintani, Hiromoto
    Mizuguchi, Masayuki
    Nishi, Kohichi
    Fujimura, Masaki
    Nakao, Shinji
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3723 - 3728
  • [50] Phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer
    Kim, B.
    Kim, H.
    Kim, T.
    Lee, H.
    Lee, B.
    Kim, J.
    Nam, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345